- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05098288
Clinical Effectiveness of the MultiCentre Pain Monitor to Guide and Personalize Psychological Treatments: A Single Case Design
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Anxiety and depressive disorders, commonly known as emotional disorders (EDs), are the most frequent mental health problems why patients seek for medical care globally. According to recent epidemiologic studies, lifetime prevalence rates reveal that anxiety and depression disorders affect approximately an estimated 31.9% and 33.7% of people worldwide, respectively. In Spain, a nationwide study showed a prevalence of anxiety and depression disorders of 5.2% and 4.1%, approximately. Consequently, EDs lead to considerable direct and indirect economic losses for countries, as well as a great negative impact on the quality of life and overall functioning of individuals. Adding up to the previous, the current covid-19 pandemic not only has boosted the incidence of mental disorders in healthy people, but also has exacerbated emotional problems in vulnerable populations.
Encouragingly, the effectiveness of psychotherapy for the treatment of EDs, especially cognitive behavioural therapy (CBT), has been supported by a vast amount of scientific evidence. In particular, Internet-delivered CBT (iCBT), where patients sign in to a safe website to access online psychotherapeutic materials within several modules, has emerged in recent years as an effective alternative to face-to-face psychotherapy in an attempt to reduce costs, save therapists' and clients' time, bring psychological treatments closer to the population, and disseminate interventions easily. The growth of digital care has become even more obvious during the covid-19 pandemic and the associated quarantine, where great efforts have been made to adapt evidence-based treatments to a new digital format. Therefore, the current situation has become an opportunity to develop and implement promising digital interventions, which are now more sensible than ever.
To make evidence-based treatments even more accessible, extensions and innovations of CBT have been developed in recent years. The latest research supports a transdiagnostic perspective for the treatment of EDs, where cognitive-behavioural techniques are included to target different EDs altogether. Indeed, the transdiagnostic approach appears to be an effective alternative to single disorder interventions in order to address the high comorbidity rates between anxiety and depressive disorders, as well as the shared mechanisms and the overlapping symptomatology across different disorders which play an essential role in the onset and maintenance of them. In particular, the Unified Protocol (UP), a transdiagnostic extension of CBT which works on regulate emotions in a more adaptive way through different core treatment modules, has been developed for the treatment of EDs. Specifically, the UP shows promising effects not only when delivered onsite, but also online, which makes it an excellent psychological approach to reach a large number of individuals with a single treatment protocol.
In this line, some interesting proposals emphasize the need for a paradigm shift from randomized controlled trials that work on average towards personalized treatments that allow to focus more on the individual (to avoid what group average can mask). In particular, measurement-based care, which consists of routine patient monitoring, periodic feedback to the therapist (or both therapist and patient), and adaptation of the intervention according to such feedback appears to be a feasible option in order to adapt treatments to patients' needs. Fortunately, with the rapid growth of new technologies in our society such as mobile applications (apps), measurement-based care can be implemented more effectively as the apps can be used as support tools for the assessment of several psychological outcome variables. This procedure is commonly known as Ecological Momentary Assessment (EMA) and can help overcome some of the obstacles that traditional, retrospective face-to-face assessments hold. EMA has the potential to assess patients repeatedly and frequently over time, allows to observe fluctuations in patient outcomes, and early interventions can be administered in response to pre-set clinical alarms.
To our knowledge, studies that use technology to improve the management of emotional problems have generally opted for using apps that report on the evolution of treatment to obtain more reliable measures of the evolution of patients or, more frequently, have used different technologies such as web pages or apps to facilitate self-applied treatments based on pre-established modules. The present study goes one step further and explores not only the usefulness of the EMA by means of an app for the improvement of the assessment process of patients with emotional problems/EDs, but also the feasibility of using it to make adjustments in real time or very short-term (e.g., in weekly visits) during the psychotherapeutic process, resembling an ecological momentary intervention (EMI). Several studies have supported the use of EMA to deliver the most personalized feedback or psychological support in real life for a given patient in order to enhance psychotherapy effectiveness and facilitate tailored treatments.
Objectives The current study aims at testing the clinical effectiveness of an app-based system called Multicentric Pain Monitor, which has been recently validated in an empirical study, that monitors individuals with EDs daily and is used as an adjunct tool to the self-applied Internet-delivered transdiagnostic program (UP). The main goal is to explore whether the treatment with the innovative information and communication technologies (ICT) support is effective for persons with emotional disorders.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Carlos Suso-Ribera, Ph.D.
- Phone Number: 964 387643
- Email: susor@uji.es
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Anxiety or depression problems are the main problematic symptoms
- The patient is over 18 years of age
- The patient is fluent in the language in which the therapy is performed (Spanish in the present study)
- The patient is able to attend to the evaluation and treatment sessions
- The patient signs the informed consent form
Exclusion Criteria:
- The patient presents a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder) or there is suicide risk at the time of assessment
- The patient has used substances in the last three months (excluding cannabis, coffee, and / or nicotine)
- The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles in the past 12 months or is currently receiving psychological treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: App + Unified Protocol Arm
Participants at this condition will be daily monitored by the app (Multicentre Pain Monitor) while they are administered a self-applied online transdiagnostic intervention (Unified protocol) for their emotional disorders. Alarms will be generated in the face of certain pre-set undesired events. Therapists will receive pre-set clinical alarms in real time in the presence of relevant clinical events previously determined by the clinical staff (e.g., clinical worsening or no improvement of functionality, mood or psychological mechanisms worked in therapy). This information will be used to make clinical decisions in a short period of time (e.g., call the patient, or send additional therapeutic material by mail or through the app (momentary ecological intervention), or for its implementation during the course of psychological therapy in order to make the therapy more efficient, safe, personalized and adapted to the needs of the patient |
The intervention will consist in a self-applied online transdiagnostic intervention for emotional problems together with an app-based EMA.
In terms of monitoring, the Multicentre Pain Monitor is a mobile app whose contents have been adapted to conduct ecological momentary assessments in different health conditions.
The app assesses important psychological variables, namely anxiety, depressive symptoms,etc.
Participants respond daily to the questions in the app.
In terms of the online self-applied intervention, the Unified Protocol is a transdiagnostic extension of CBT which works on regulate emotions in a more adaptive way through 5 core treatment modules: present-focused emotional awareness, cognitive flexibility, identification and prevention of emotional avoidance patterns, increasing awareness and tolerance to emotion-elicited physical sensations, and graded (interoceptive and situational) exposure procedures.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Anxiety
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 0 (not at all) to 3 (completely), "how was your level of anxiety today?"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in Depression
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 0 (not at all) to 3 (completely), "how was your level of depression today?"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Activity level
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 0 (minimum) to 100 (maximum), "what was your activity level today?"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in Emotion Conceptualization
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 1 (not at all) to 5 (completely), "I see difficult emotions as something bad"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in Emotional Avoidance
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 1 (not at all) to 5 (completely), "Today, I tried to get rid of my unpleasant emotions at all costs"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in present-focused emotional awareness (Mindfulness)
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 1 (not at all) to 5 (completely), "Today, it was easy for me to pay attention to the present moment non-judgmentally"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in Cognitive Flexibility
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 1 (not at all) to 5 (completely), "Today, I was able to consider different interpretations for the bad things that happened to me"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in Exposure to situations
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 1 (not at all) to 5 (completely), "Today, I tried to avoid potentially uncomfortable situations"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Change in Exposure to physical sensations
Time Frame: Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
In a scale from 1 (not at all) to 5 (completely), "Today, I tried to get rid of my unpleasant physical sensations at all costs"
|
Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Patricia Gual- Montolio, Universitat Jaume I
- Study Chair: Juana Maria Bretón-López, Ph.D., Universitat Jaume I
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ROMEMIUJI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emotional Disorder
-
Peking UniversityNot yet recruitingEmotional Disorder | Emotional DistressChina
-
Peking UniversityBeijing Tiantan Hospital; Capital Medical University; Nanjing Brian Hospital; Foshan...RecruitingEmotional DisorderChina
-
Methodist Health SystemRecruiting
-
Peking University People's HospitalUnknownEmotional Disorder
-
University of MiamiCompletedDepression | Obsessive-Compulsive Disorder | Anxiety Disorders | Emotional Disorder | Adolescent - Emotional ProblemUnited States
-
Duke UniversityNational Institute of Mental Health (NIMH)RecruitingMood Disorders | Obsessive-Compulsive Disorder | Anxiety Disorders | OCD | Borderline Personality Disorder | Stress Disorder | Emotional Distress | Emotion Regulation | Eating Disorders | Emotion Dysregulation | Emotional Dysfunction | Emotional Impulsivity | Emotional Instability | Impulse Control Disorder | Emotional...United States
-
Peking UniversityNot yet recruitingEmotional Disorder | Emotional DistressChina
-
Instituto de Investigación Sanitaria AragónRecruitingDepressive Disorder | Anxiety Disorders | Emotional DisorderSpain
-
Universitat Jaume INot yet recruitingEmotional Disorder
-
University of Colorado, DenverChildren's Hospital Colorado; American Psychological FoundationCompletedEmotional DisorderUnited States
Clinical Trials on Multicentre Pain Monitor + Unified Protocol
-
Boston University Charles River CampusUniversity of Kentucky; Harvard School of Public Health (HSPH)RecruitingDepressive Disorder | Anxiety DisordersUnited States
-
Kessler FoundationRecruiting
-
University of Buenos AiresNot yet recruitingTo Assess the Clinical Usefulness and Acceptability Level of the UP Online Group Format in Argentina as Well as Participants' SatisfactionArgentina
-
Örebro University, SwedenÖrebro County Council; Uppsala County Council, SwedenCompletedChronic Pain and Comorbid Emotional Problems
-
Duke UniversityNational Institute on Aging (NIA)Active, not recruiting
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Massachusetts General HospitalRecruitingEmotion Regulation | Suicide and Self-harmUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingEmotional EatingSpain
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedMood Disorders | Anxiety DisordersUnited States
-
Northwestern UniversityCompletedLower Urinary Tract Symptoms | Urinary Incontinence | Anxiety | Pelvic Floor Disorders | Nocturia | Urinary Urgency | Urinary Frequency/Urgency | Urinary Hesitancy | Urinary StrainingUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedDepression | Anxiety | Traumatic Stress DisordersUnited States